Trial intelligence / Profile preview

Promethazine for prevention and treatment of postoperative nausea and vomiting

ChiCTR2100054495Phase 4Recruiting

Sponsor
Gansu Provincial People's Hospital
Start
Dec 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of promethazine in postoperative nausea and vomiting (PONV) (4 arms), sponsored by Gansu Provincial People's Hospital. Primary endpoint: Postoperative nausea and vomiting. Started Dec 2021; status: recruiting.

02

Drugs

promethazine
03

Conditions

postoperative nausea and vomiting (PONV)

Beyond the preview

Go deeper on ChiCTR2100054495.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2100054495.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call